Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study

• Hauptverfasser: Zhao-xin Wu (Verfasst von), Chen-jing Wang (Verfasst von), Ping Shi (Verfasst von), Yan-ping Liu (Verfasst von), Ting Li (Verfasst von), Fei-fei Sun (Verfasst von), Yao Fu (Verfasst von), Xiao-meng Gao (Verfasst von), Ya-ping Ma (Verfasst von), Yu Cao (Verfasst von)
• Format: Buch
• Veröffentlicht: Adis, Springer Healthcare, 2023-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background and Objective Abiraterone acetate tablet is an inhibitor of androgen synthesis, primarily for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This study evaluated the bioequivalence and pharmacokinetics of the reference and test formulations of abiratero...